Eagle Strategies LLC Merck & Co., Inc. Transaction History

Eagle Strategies LLC

$550 Million
Q3 2024

A detailed history of Eagle Strategies LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eagle Strategies LLC holds 15,896 shares of MRK stock, worth $1.64 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

15,896

Previous 16,883 5.85%

Holding current value

$1.64 Million

Previous $2.09 Million 13.64%

% of portfolio

0.33%

Previous 0.4%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$111.15 - $128.97 $109,705 - $127,293	-987 Reduced 5.85%	15,896 $1.81 Million
Q2 2024 Aug 07, 2024	BUY	$123.8 - $132.96 $1.25 Million - $1.34 Million	10,107 Added 149.16%	16,883 $2.09 Million
Q1 2024 Apr 22, 2024	SELL	$113.24 - $131.95 $1.14 Million - $1.33 Million	-10,047 Reduced 59.72%	6,776 $894,000
Q4 2023 Jan 26, 2024	SELL	$100.18 - $109.02 $3,806 - $4,142	-38 Reduced 0.23%	16,823 $1.83 Million
Q3 2023 Nov 07, 2023	BUY	$102.95 - $114.33 $26,664 - $29,611	259 Added 1.56%	16,861 $1.74 Million
Q2 2023 Aug 02, 2023	SELL	$108.61 - $118.38 $58,975 - $64,280	-543 Reduced 3.17%	16,602 $1.92 Million
Q1 2023 Apr 21, 2023	BUY	$102.94 - $114.86 $17,190 - $19,181	167 Added 0.98%	17,145 $1.82 Million
Q4 2022 Feb 03, 2023	BUY	$87.44 - $112.11 $28,243 - $36,211	323 Added 1.94%	16,978 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $30,092 - $33,805	356 Added 2.18%	16,655 $1.43 Million
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $32,644 - $37,004	-391 Reduced 2.34%	16,299 $1.49 Million
Q1 2022 May 02, 2022	SELL	$73.51 - $82.4 $4,484 - $5,026	-61 Reduced 0.36%	16,690 $1.37 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $1.21 Million - $1.52 Million	16,751 New	16,751 $1.28 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Strategies LLC with notifications on news.

Account

Eagle Strategies LLC Merck & Co., Inc. Transaction History